Day: June 11, 2022
TORONTO, June 11, 2022 (GLOBE NEWSWIRE) — It is with great sorrow that Rogers Communications Inc. (“Rogers”) today announces the passing of Loretta Rogers at the age of eighty-three, peacefully in her home, surrounded by family.
A beloved wife to the late Ted Rogers, mother, and grandmother, Loretta lived a full and vibrant life who dedicated herself to family, friendship, community and business.
Loretta believed passionately in Ted’s vision for the company, and through 45 years of a deeply loving marriage, Loretta and Ted supported each other to grow Rogers into the company that it is today. Following Ted’s death, Loretta devoted herself to keeping his vision alive and making Rogers the absolute best it could be.
Mrs. Rogers served as a corporate director of Rogers Communications since 1964 and was a member of the...
HII Christens Richard M. McCool Jr. (LPD 29)
Written by Customer Service on . Posted in Public Companies.
Richard M. McCool Jr. (LPD 29) Christening
Ship’s Sponsors Shana McCool and Kate Oja christened Richard M. McCool Jr. (LPD 29), the U.S. Navy’s 13th San Antonio-class amphibious transport dock at HII’s Ingalls Shipbuilding division. LPD 29 is named for McCool and Oja’s grandfather, Capt. Richard M. McCool Jr., a Medal of Honor recipient.Also pictured are Capt. Jeffrey Baker, prospective commanding officer, Richard M. McCool Jr. (LPD 29); Kari Wilkinson, Ingalls Shipbuilding president; and Erik Raven, under secretary of the Navy.PASCAGOULA, Miss., June 11, 2022 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today that its Ingalls Shipbuilding division christened the company’s 13th amphibious transport dock, Richard M. McCool Jr. (LPD 29), constructed for the U.S. Navy.
“For nearly two decades, we have had the opportunity...
CRISPR Therapeutics Presents Positive Results from its Phase 1 COBALT™-LYM Trial of CTX130™ in Relapsed or Refractory T Cell Malignancies at the 2022 European Hematology Association (EHA) Congress
Written by Customer Service on . Posted in Public Companies.
-70% overall response rate (ORR) and 30% complete response (CR) rate in peripheral T-cell lymphoma (PTCL) and cutaneous T cell lymphoma (CTCL) at Dose Level 3 (DL3) and above; clinical benefit for 90% of patients-
-Well tolerated safety profile across all dose levels with no DLTs observed-
ZUG, Switzerland and CAMBRIDGE, Mass., June 11, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today presented positive results from the Company’s ongoing Phase 1 COBALT™-LYM trial evaluating the safety and efficacy of CTX130™, its wholly-owned allogeneic CAR-T cell therapy targeting CD70 for the treatment of both solid tumors and certain hematologic malignancies.
“We are very pleased with the preliminary results from our COBALT-LYM...
Information for the Extraordinary General Meeting of Shareholders of Snaige AB
Written by Customer Service on . Posted in Public Companies.
Provided is the additional information for the Extraordinary General Meeting of Shareholders (hereinafter – the Meeting) of Snaige AB (hereinafter – Company) which is convened on June 23rd, 2022 10 a.m.
on the agenda item No. 2 .: Regarding the approval of the project of the Company’s restructuring plan.
The Company’s shareholders are invited to participate in the Meeting and vote on the agenda items in writing, by filling voting ballot in advance and submitting to the Company (by address Pramones str. 6, Alytus, Lithuania). The document confirming the right to vote must also be sent together with voting ballot. Based on the COVID-19 morbidity rates in the country it is recommended to firstly consider the possibilities of receiving the General Voting Ballot and advance voting remotely, and to come to the Company’s...
Revival Gold Resumes Drilling the High-Grade Joss Target
Written by Customer Service on . Posted in Public Companies.
Figure 1
Planned 2022 Joss Drill TargetsTORONTO, June 11, 2022 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”), is pleased to announce that it has resumed drilling on the high-grade Joss target at the Company’s Beartrack-Arnett Gold Project (“Beartrack-Arnett”) located in Idaho, USA.
Approximately 2,000 meters of core drilling in three holes are planned this summer at Joss. Drilling will focus on the continued definition and expansion of the one-kilometer trend of high-grade gold mineralization with underground mining and mill potential. High-grade intercepts from the eighteen core holes previously drilled on the Joss trend typically run from 4–11 g/t gold and are estimated to range between 1–5 meters in true width (see Revival Gold press release dated March 1st, 2021). Drilling...
Park Street A/S – Reduction of share capital
Written by Customer Service on . Posted in Public Companies.
With reference to company announcement of 25 April 2022 regarding the general meeting’s approval of share capital reduction, Park Street A/S hereby announces that completion of the share capital reduction has now been registered with the Danish Business Authority.
The nominal value of the share capital reduction is DKK 10,338,160 corresponding to 10,338,160 shares of nominal value of DKK 1 held by Park Street A/S as treasury shares prior to the registration. Accordingly, Park Street A/S’ share capital is now reduced from DKK 67,513,732 to DKK 57,175,572. Consequently, Park Street A/S no longer holds any class A treasury shares nor any class B treasury shares.
Prior to the share capital reduction, the treasury shares held by Park Street A/S corresponded to 15.31% of the company’s total share capital. In accordance with Section 31 of the...
Genmab Announces Late-Breaking Phase 2 Trial Results of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Relapsed/Refractory Large B-cell Lymphoma (LBCL) Patients Presented at European Hematology Association (EHA) Presidential Symposium
Written by Customer Service on . Posted in Public Companies.
Media Release
COPENHAGEN, Denmark; June 11, 2022 Epcoritamab demonstrated clinically meaningful efficacy in challenging to treat, highly refractory LBCL patients, including patients previously treated with chimeric antigen receptor (CAR) T-cell therapy
Total patient population achieved overall response rate (ORR) of 63 percent and complete response (CR) of 39 percent; CAR T-naïve patients achieved 69 percent ORR and 42 percent CR; patients previously treated with CAR T achieved a 54 percent ORR and 34 percent CR
Manageable safety profile consistent with previous findings was observed
Results were reported as part of a late-breaking oral presentation selected for the Presidential Symposium at the EHA Annual CongressGenmab A/S (Nasdaq: GMAB) announced today primary results from the large B-cell lymphoma (LBCL) expansion cohort in the...
Honey Badger to Acquire 100% of the Cachinal Silver-Gold Project in Chile, with 16.3 Million Ounces of Indicated and 2.5 Million Ounces of Inferred Silver Resources
Written by Customer Service on . Posted in Public Companies.
TORONTO, June 10, 2022 (GLOBE NEWSWIRE) — Honey Badger Silver Inc. (TSX-V: TUF) (“Honey Badger” or the “Company”) is pleased to announce that it has entered into a non-binding term sheet (the “Term Sheet”) to acquire from Aftermath Silver Ltd. (“Aftermath”) its 100% interest in the Cachinal De La Sierra Silver-Gold Project (the “Cachinal Project” or “Cachinal”), located in the Cachinal de la Sierra area in Chile’s Antofagasta region (Region II). The proposed transaction includes an exclusivity period that ends on August 15, 2022. Honey Badger and Aftermath are working diligently to finalize a definitive agreement on or before this date.
Cachinal Project HighlightsOpen-pit Indicated Resource of 15.03 Moz of silver grading 97 g/t of silver and 20.05Koz of gold grading 0.13 g/t gold;
Open-pit Inferred Resource of 0.41 Moz...
Exela Technologies Announces Dividend on Series B Preferred Stock
Written by Customer Service on . Posted in Dividend Reports And Estimates.
IRVING, Texas, June 10, 2022 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela”) (NASDAQ: XELA, XELAP), today announced that its Board of Directors has declared the payment of a dividend on the Company’s outstanding 6.00% Series B Cumulative Perpetual Convertible Preferred Stock (“Series B Preferred Stock”).
In accordance with the terms of the Series B Preferred Stock, the Board of Directors declared a dividend of $0.46 per share of Series B Preferred Stock for the quarter ending June 30, 2022 and inclusive of the 20 days in March 2022 when the Series B Preferred Stock was first issued. This dividend is payable in cash on June 30, 2022, to Series B Preferred stockholders of record as of June 20, 2022.
About Exela Technologies
Exela Technologies is a business process automation (BPA) leader, leveraging a global footprint...
ApartmentLove Closes Second Tranche of Non-Brokered Private Placement of Units
Written by Customer Service on . Posted in Public Companies.
NOT FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW.
CALGARY, Alberta, June 10, 2022 (GLOBE NEWSWIRE) — ApartmentLove Inc. (CSE: APLV) (“ApartmentLove” or the “Company”), a leading provider of online home and apartment rental marketing services catering to landlords and renters in 30-countries on 5-continents around the world, is pleased to announce that it has closed the second tranche of its previously announced non-brokered private placement of up to 10,000,000 units of the Company (“Units”) at a price of $0.15 per Unit, for gross proceeds up to a maximum of $1,500,000 (the “Private Placement”). The securities issued in connection with the Private Placement are subject to a four-month plus one day hold period, in accordance with applicable...